The HepA/B vaccine PGD supports the provision of HepA/B vaccine to individuals aged over-one-year requiring pre-exposure immunisation against hepatitis A and B virus.
The HepA/B vaccine PGD is valid from 1 November 2017 to 31 October 2019.
The HepA/B vaccine (temp) has been issued for use during the global shortage of hepatitis vaccine affecting UK supply. It supports the administration of HepA/B vaccine to individuals requiring pre-exposure or post-exposure immunisation against hepatitis A or B virus in accordance with PHE temporary dose sparing advice, to preserve and prioritise monovalent hepatitis vaccine stock for those with the greatest ability to benefit and highest immediate need.
The HepA/B vaccine (temp) PGD is valid from 1 November 2017 to 31 October 2018.
Practitioners must not use these PGD templates until they have been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.
These PGD templates should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.
from Public Health England - Activity on GOV.UK https://www.gov.uk/government/publications/hepatitis-ab-vaccine-patient-group-direction-template
via IFTTT
source https://tennissurfacingspecifications.tumblr.com/post/167448336359
No comments:
Post a Comment